Publications by authors named "Mizuki Nishino"

100Publications

Tumor volume dynamics and tumor growth rate in -rearranged advanced non-small-cell lung cancer treated with crizotinib.

Eur J Radiol Open 2020 28;7:100210. Epub 2020 Jan 28.

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Ave., Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejro.2019.12.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569410PMC
January 2020

Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitors.

Eur J Radiol 2020 Sep 10;132:109275. Epub 2020 Sep 10.

Department of Imaging, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA; Department of Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2020.109275DOI Listing
September 2020

CT Volumetry for Lung-RADS Classification of Solid Nodules.

Authors:
Mizuki Nishino

Radiology 2020 Sep 15:203298. Epub 2020 Sep 15.

From the Department of Imaging, Dana-Farber Cancer Institute and Department of Radiology, Brigham and Women's Hospital, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020203298DOI Listing
September 2020

Radiomics to Predict Invasiveness of Part-Solid Adenocarcinoma of the Lung.

Authors:
Mizuki Nishino

Radiology 2020 Nov 25;297(2):459-461. Epub 2020 Aug 25.

From the Department of Imaging, Dana-Farber Cancer Institute, Boston, Mass; and Department of Radiology, Brigham and Women's Hospital, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020202273DOI Listing
November 2020

Incidence of Pseudoprogression during Immune Checkpoint Inhibitor Therapy for Solid Tumors: A Systematic Review and Meta-Analysis.

Radiology 2020 Oct 4;297(1):87-96. Epub 2020 Aug 4.

From the Department of Radiology and Research Institute of Radiology, Asan Image Metrics, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Republic of Korea (H.J.P., K.W.K., C.H.S.); WHO Collaborating Center for Pharmaceutical Policy and Regulation, Department of Pharmaceutical Science, Utrecht University, Utrecht, the Netherlands (J.P.); Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea (S.Y.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (H.H., M.N.); and Department of Imaging, Dana-Farber Cancer Institute, Boston, Mass (M.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020200443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526949PMC
October 2020

Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2020 Sep 9;21(5):e435-e444. Epub 2020 Mar 9.

Department of Pulmonary Medicine and Critical Care, Centre Hospitalier et Université de Bourgogne, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2020.02.025DOI Listing
September 2020

Radiographic patterns of symptomatic radiation pneumonitis in lung cancer patients: Imaging predictors for clinical severity and outcome.

Lung Cancer 2020 07 30;145:132-139. Epub 2020 Apr 30.

Department of Imaging, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA; Department of Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2020.03.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316126PMC
July 2020

Imaging of Precision Therapy for Lung Cancer: Current State of the Art.

Radiology 2019 10 6;293(1):15-29. Epub 2019 Aug 6.

From the Departments of Imaging (H.P., M.N.) and Medical Oncology (M.M.A.), Dana-Farber Cancer Institute, and Departments of Radiology (H.P., H.H., M.N.), Pathology (L.M.S.), and Medicine (M.M.A.), Brigham and Women's Hospital, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019190173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776234PMC
October 2019

Using CT to Evaluate Visceral Pleural Invasion: Caution Is Advised.

Authors:
Mizuki Nishino

Radiology 2019 Sep 30;292(3):750-751. Epub 2019 Jul 30.

From the Department of Radiology, Brigham and Women's Hospital, Boston, Mass; and Department of Imaging, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019191478DOI Listing
September 2019

The incidence of ALK inhibitor-related pneumonitis in advanced non-small-cell lung cancer patients: A systematic review and meta-analysis.

Lung Cancer 2019 06 10;132:79-86. Epub 2019 Apr 10.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.04.015DOI Listing
June 2019

Time-resolved quantitative evaluation of diaphragmatic motion during forced breathing in a health screening cohort in a standing position: Dynamic chest phrenicography.

Eur J Radiol 2019 Apr 31;113:59-65. Epub 2019 Jan 31.

Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, 3-1-24 Matsuyama, Kiyose, Tokyo, 204-8522, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2019.01.034DOI Listing
April 2019

Frequency and imaging features of abdominal immune-related adverse events in metastatic lung cancer patients treated with PD-1 inhibitor.

Abdom Radiol (NY) 2019 05;44(5):1917-1927

Department of Medical Oncology and Department of Medicine, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-019-01935-2DOI Listing
May 2019

Decreased and slower diaphragmatic motion during forced breathing in severe COPD patients: Time-resolved quantitative analysis using dynamic chest radiography with a flat panel detector system.

Eur J Radiol 2019 Mar 4;112:28-36. Epub 2019 Jan 4.

Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, 3-1-24 Matsuyama, Kiyose, Tokyo 204-8522, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2018.12.023DOI Listing
March 2019

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.

Oncologist 2019 08 29;24(8):e749-e754. Epub 2019 Jan 29.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693709PMC
August 2019

Perinodular Radiomic Features to Assess Nodule Microenvironment: Does It Help to Distinguish Malignant versus Benign Lung Nodules?

Authors:
Mizuki Nishino

Radiology 2019 Mar 18;290(3):793-795. Epub 2018 Dec 18.

From the Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018182619DOI Listing
March 2019

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.

Eur J Radiol 2018 Dec 23;109:68-76. Epub 2018 Oct 23.

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Ave., Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2018.10.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294464PMC
December 2018

Imaging of Histiocytosis in the Era of Genomic Medicine.

Radiographics 2019 Jan-Feb;39(1):95-114. Epub 2018 Nov 30.

From the Departments of Radiology (H.P., M.N.), Pathology (J.L.H.), and Medical Oncology (E.D.J.), Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/rg.2019180054
Publisher Site
http://dx.doi.org/10.1148/rg.2019180054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357950PMC
March 2020

Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.

Radiology 2019 01 20;290(1):9-22. Epub 2018 Nov 20.

From the Departments of Radiology (M.N., H.H.), Medical Oncology (F.S.H.), and Medicine (F.S.H.), Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/radiol.2018181349
Publisher Site
http://dx.doi.org/10.1148/radiol.2018181349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312436PMC
January 2019

Reply to the comments on: Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC.

Lung Cancer 2019 01 8;127:168. Epub 2018 Nov 8.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.11.005DOI Listing
January 2019

Tumor Response Assessment for Precision Cancer Therapy: Response Evaluation Criteria in Solid Tumors and Beyond.

Authors:
Mizuki Nishino

Am Soc Clin Oncol Educ Book 2018 May;38:1019-1029

From the Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/EDBK_201441
Publisher Site
http://dx.doi.org/10.1200/EDBK_201441DOI Listing
May 2018

Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients: Meta-analysis of incidence and risk factors of EGFR-TKI pneumonitis in NSCLC.

Lung Cancer 2018 09 30;123:60-69. Epub 2018 Jun 30.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.06.032DOI Listing
September 2018

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib.

J Thorac Oncol 2018 08 6;13(8):e131-e133. Epub 2018 Apr 6.

Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102421PMC
August 2018

Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event.

Cancer Immunol Res 2018 06 5;6(6):630-635. Epub 2018 Apr 5.

Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-17-0715DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984707PMC
June 2018

Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy.

J Clin Oncol 2018 03 17;36(9):850-858. Epub 2018 Jan 17.

F. Stephen Hodi and Mizuki Nishino, Dana-Farber Cancer Institute, Boston, MA; Marcus Ballinger, Benjamin Lyons, Chris McKenna, Ina Rhee, Gregg Fine, Nathan Winslow, and Daniel S. Chen, Genentech, South San Francisco, CA; Jean-Charles Soria, AstraZeneca, Gaithersburg, MD; Josep Tabernero, Universitat Autònoma de Barcelona, Barcelona, Spain; Thomas Powles, Queen Mary University of London, London, United Kingdom; David Smith, Compass Oncology, Vancouver, WA; Axel Hoos, GlaxoSmithKline, Collegeville, PA; Ulrich Beyer, Roche Innovation Center, Basel, Switzerland; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.1644DOI Listing
March 2018

Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Radiographics 2017 Sep-Oct;37(5):1371-1387

From the Departments of Radiology (M.N., H.H., N.H.R.) and Pathology (L.M.S.), Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.2017170015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621730PMC
December 2017

Tumor Response Dynamics of Advanced Non-small Cell Lung Cancer Patients Treated with PD-1 Inhibitors: Imaging Markers for Treatment Outcome.

Clin Cancer Res 2017 Oct 5;23(19):5737-5744. Epub 2017 Jul 5.

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-1434DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626605PMC
October 2017

Monitoring immune-checkpoint blockade: response evaluation and biomarker development.

Nat Rev Clin Oncol 2017 Nov 27;14(11):655-668. Epub 2017 Jun 27.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.88DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650537PMC
November 2017

Drug-Related Pneumonitis in the Era of Precision Cancer Therapy.

JCO Precis Oncol 2017 26;1. Epub 2017 May 26.

: Brigham and Women's Hospital; and Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446404PMC
May 2017

Osimertinib in EGFR T790M-Positive Lung Cancer.

N Engl J Med 2017 05;376(20):1992-3

Dana–Farber/Brigham and Women’s Cancer Center, Boston, MA

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1703339
Publisher Site
http://dx.doi.org/10.1056/NEJMc1703339DOI Listing
May 2017

Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features.

Occup Environ Med 2017 10 3;74(10):756-761. Epub 2017 May 3.

Department of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/oemed-2016-104178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701783PMC
October 2017

Risk of Bias and Heterogeneity-Reply.

JAMA Oncol 2017 06;3(6):858-859

Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.0160DOI Listing
June 2017

Headache in the Setting of Immunotherapy Treatment for Metastatic Melanoma.

JAMA Oncol 2017 05;3(5):703-704

Harvard Medical School, Boston, Massachusetts2Department of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts3Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.6611DOI Listing
May 2017

Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib.

Eur J Radiol 2017 Mar 26;88:15-20. Epub 2016 Dec 26.

Department of Medical Oncology and Department of Medicine Dana-Farber Cancer Institute and Brigham and Women's Hospital 450 Brookline Ave., Boston MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2016.12.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560072PMC
March 2017

Programmed Death-1/Programmed Death Ligand-1 Inhibitor-Related Pneumonitis and Radiographic Patterns.

J Clin Oncol 2017 05 6;35(14):1628-1629. Epub 2017 Feb 6.

Mizuki Nishino, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA; and Hiroto Hatabu, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.0434
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.0434DOI Listing
May 2017

Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.

Korean J Radiol 2017 Jan-Feb;18(1):42-53. Epub 2017 Jan 5.

Department of Radiology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3348/kjr.2017.18.1.42DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240494PMC
August 2017

Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients.

J Immunother Cancer 2016 20;4:84. Epub 2016 Dec 20.

Department of Medical Oncology and Department of Medicine Dana-Farber Cancer Institute and Brigham and Women's Hospital, 450 Brookline Ave., Boston, MA 02215 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0193-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168591PMC
December 2016

Low dose chest CT protocol (50 mAs) as a routine protocol for comprehensive assessment of intrathoracic abnormality.

Eur J Radiol Open 2016 27;3:86-94. Epub 2016 Apr 27.

Department of Radiology, Brigham and Women's Hospital, 75 Francis Street Boston, MA 02115, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejro.2016.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144113PMC
April 2016

PD-1 inhibitor-related pneumonitis in lymphoma patients treated with single-agent pembrolizumab therapy.

Br J Haematol 2018 03 11;180(5):752-755. Epub 2016 Nov 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.14441
Publisher Site
http://dx.doi.org/10.1111/bjh.14441DOI Listing
March 2018

Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.

JAMA Oncol 2016 Dec;2(12):1607-1616

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2016.2453DOI Listing
December 2016

Pseudoprogression and Measurement Variability.

Authors:
Mizuki Nishino

J Clin Oncol 2016 10 25;34(28):3480-1. Epub 2016 Jul 25.

Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6759DOI Listing
October 2016

Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a "common language" for the new arena of cancer treatment.

Authors:
Mizuki Nishino

J Immunother Cancer 2016 21;4:30. Epub 2016 Jun 21.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215 USA.

View Article

Download full-text PDF

Source
http://jitc.biomedcentral.com/articles/10.1186/s40425-016-01
Publisher Site
http://dx.doi.org/10.1186/s40425-016-0134-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915158PMC
June 2016

Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.

Cancer Immunol Res 2016 Apr 10;4(4):289-93. Epub 2016 Feb 10.

Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818710PMC
April 2016

Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.

Acad Radiol 2016 Mar 8;23(3):329-36. Epub 2016 Jan 8.

Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2015.11.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744559PMC
March 2016

Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach.

Eur J Cancer 2016 Jan 4;53:163-70. Epub 2016 Jan 4.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.10.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724503PMC
January 2016

Clinical Implications of Variant ALK FISH Rearrangement Patterns.

J Thorac Oncol 2015 Nov;10(11):1648-52

*Brigham and Women's Hospital, Boston, Massachusetts; and †Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634010PMC
November 2015

Pulmonary cysts identified on chest CT: are they part of aging change or of clinical significance?

Thorax 2015 Dec 29;70(12):1156-62. Epub 2015 Oct 29.

Department of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2015-207653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848007PMC
December 2015

Anti-PD-1-Related Pneumonitis during Cancer Immunotherapy.

N Engl J Med 2015 Jul;373(3):288-90

Dana-Farber/Brigham and Women's Cancer Center, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1505197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539956PMC
July 2015

Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.

Cancer Immunol Res 2015 Oct 22;3(10):1185-92. Epub 2015 Jun 22.

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/cgi/doi/10.1158/232
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-15-0102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596761PMC
October 2015

Advanced High-Grade Serous Ovarian Cancer: Frequency and Timing of Thoracic Metastases and the Implications for Chest Imaging Follow-up.

Radiology 2015 Dec 5;277(3):733-40. Epub 2015 Jun 5.

From the Department of Radiology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, 75 Francis St, Boston, MA 02115 (A.B.S., A.C.O., B.S., S.H.T., M.N., A.D.V.d.A., N.H.R.); and Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Mass (S.C.).

View Article

Download full-text PDF

Source
http://pubs.rsna.org/doi/10.1148/radiol.2015142467
Publisher Site
http://dx.doi.org/10.1148/radiol.2015142467DOI Listing
December 2015

Hormonal therapy in oncology: a primer for the radiologist.

AJR Am J Roentgenol 2015 Jun;204(6):W620-30

1 Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.14.13604DOI Listing
June 2015

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.

J Thorac Oncol 2015 Jun;10(6):951-9

*Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; †Department of Imaging, Dana Farber Cancer Institute, Boston, Massachusetts; ‡Department of Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, New York; §Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; and ‖Thoracic Oncology Program, Dana Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443847PMC
June 2015

Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma.

Cancer Immunol Res 2015 Sep 5;3(9):986-91. Epub 2015 May 5.

Melanoma Disease Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561189PMC
September 2015